Literature DB >> 19475538

Empirical vs natural weighting in random effects meta-analysis.

Jonathan J Shuster1.   

Abstract

This article brings into serious question the validity of empirically based weighting in random effects meta-analysis. These methods treat sample sizes as non-random, whereas they need to be part of the random effects analysis. It will be demonstrated that empirical weighting risks substantial bias. Two alternate methods are proposed. The first estimates the arithmetic mean of the population of study effect sizes per the classical model for random effects meta-analysis. We show that anything other than an unweighted mean of study effect sizes will risk serious bias for this targeted parameter. The second method estimates a patient level effect size, something quite different from the first. To prevent inconsistent estimation for this population parameter, the study effect sizes must be weighted in proportion to their total sample sizes for the trial. The two approaches will be presented for a meta-analysis of a nasal decongestant, while at the same time will produce counter-intuitive results for the DerSimonian-Laird approach, the most popular empirically based weighted method. It is concluded that all past publications based on empirically weighted random effects meta-analysis should be revisited to see if the qualitative conclusions hold up under the methods proposed herein. It is also recommended that empirically based weighted random effects meta-analysis not be used in the future, unless strong cautions about the assumptions underlying these analyses are stated, and at a minimum, some form of secondary analysis based on the principles set forth in this article be provided to supplement the primary analysis. Copyright (c) 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19475538      PMCID: PMC3697007          DOI: 10.1002/sim.3607

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  5 in total

1.  Comments on 'Rebuttal to Carpenter et al.' Comments on 'Fixed vs random effects meta-analysis in rare event studies: the rosiglitazone link with myocardial infarction and cardiac death' by J. J. Shuster, L. S. Jones and D. A. Salmon, Statistics in Medicine 2008; 27:3912-3914.

Authors:  Joel Waksman; Christine Kollar
Journal:  Stat Med       Date:  2009-02-01       Impact factor: 2.373

2.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

3.  Fixed vs random effects meta-analysis in rare event studies: the rosiglitazone link with myocardial infarction and cardiac death.

Authors:  Jonathan J Shuster; Lynn S Jones; Daniel A Salmon
Journal:  Stat Med       Date:  2007-10-30       Impact factor: 2.373

4.  Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.

Authors:  Steven E Nissen; Kathy Wolski
Journal:  N Engl J Med       Date:  2007-05-21       Impact factor: 91.245

5.  Meta-analysis of the efficacy of a single dose of phenylephrine 10 mg compared with placebo in adults with acute nasal congestion due to the common cold.

Authors:  Christine Kollar; Heinz Schneider; Joel Waksman; Eva Krusinska
Journal:  Clin Ther       Date:  2007-06       Impact factor: 3.393

  5 in total
  22 in total

1.  A simple and robust way of concluding meta-analysis results using reported P values, standardized effect sizes, or other statistics.

Authors:  Po-Huang Chyou
Journal:  Clin Med Res       Date:  2012-05-25

Review 2.  Repetitive Transcranial Magnetic Stimulation (rTMS) Therapy in Parkinson Disease: A Meta-Analysis.

Authors:  Aparna Wagle Shukla; Jonathan J Shuster; Jae Woo Chung; David E Vaillancourt; Carolynn Patten; Jill Ostrem; Michael S Okun
Journal:  PM R       Date:  2015-08-24       Impact factor: 2.298

Review 3.  Meta-analysis methods for genome-wide association studies and beyond.

Authors:  Evangelos Evangelou; John P A Ioannidis
Journal:  Nat Rev Genet       Date:  2013-05-09       Impact factor: 53.242

4.  Is it time for the Cochrane Collaboration to reconsider its meta-analysis methodology?

Authors:  Adedayo A Onitilo
Journal:  Clin Med Res       Date:  2014-02-26

5.  Meta-analysis of safety for low event-rate binomial trials.

Authors:  Jonathan J Shuster; Jennifer D Guo; Jay S Skyler
Journal:  Res Synth Methods       Date:  2012-03       Impact factor: 5.273

6.  Estimation of treatment effect for the sequential parallel design.

Authors:  Roy N Tamura; Xiaohong Huang; Dennis D Boos
Journal:  Stat Med       Date:  2011-12-05       Impact factor: 2.373

7.  Routine probiotics for premature infants: let's be careful!

Authors:  Josef Neu
Journal:  J Pediatr       Date:  2011-01-08       Impact factor: 4.406

8.  Study factors influencing ventricular enlargement in schizophrenia: a 20 year follow-up meta-analysis.

Authors:  Angelo Sayo; Robin G Jennings; John Darrell Van Horn
Journal:  Neuroimage       Date:  2011-07-20       Impact factor: 6.556

9.  A Pocock approach to sequential meta-analysis of clinical trials.

Authors:  Jonathan J Shuster; Josef Neu
Journal:  Res Synth Methods       Date:  2013-09       Impact factor: 5.273

10.  Meta-Analysis of Rare Binary Adverse Event Data.

Authors:  Dulal K Bhaumik; Anup Amatya; Sharon-Lise Normand; Joel Greenhouse; Eloise Kaizar; Brian Neelon; Robert D Gibbons
Journal:  J Am Stat Assoc       Date:  2012-06-01       Impact factor: 5.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.